Promise and Peril of Pretomanid–Rifamycin Regimens for Drug-susceptible Tuberculosis
Crossref DOI link: https://doi.org/10.1164/rccm.202212-2262ED
Published Online: 2023-04-01
Published Print: 2023-04-01
Update policy: https://doi.org/10.1164/crossmarkpolicies
Velásquez, Gustavo E. https://orcid.org/0000-0003-1438-0692
Nahid, Payam https://orcid.org/0000-0003-2811-1311
Version of Record valid from 2026-01-22
Publication History
Published: 2023-03-31
